CEOP-Bleo

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2016
01219952016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
We performed a prospective study to investigate the efficacy and safety of triple therapy with aprepitant, ondansetron, and… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
2016
2016
Peripheral T-cell lymphomas (PTCL) have suboptimal outcomes using conventional CHOP (cyclophosphamide, doxorubicin, vincristine… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
Is this relevant?
2016
2016
BACKGROUND The number of elderly patients with diffuse large B-cell lymphoma (DLBCL) in our aging society continues to rise… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • table 2
Is this relevant?
2014
2014
Diffuse large B cell lymphoma (DLBCL) cells can be sub-classified into germinal center B cells (GCB) and non-GCB immunophenotypes… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
A 53-year-old woman with a past history of type 2 diabetes mellitus presented with a 1-year history of progressive painful… (More)
Is this relevant?
2006
2006
We analysed the treatment outcome of localized extranodal NK/T cell lymphoma initially treated with CEOP-B chemotherapy based on… (More)
Is this relevant?
2006
2006
The important prognostic factors were evaluated for T-cell non-Hodgkin lymphoma (NHL) patients in a prospective study using the… (More)
Is this relevant?
2004
2004
The main objectives of the current study were to evaluate the efficacy and safety of a CEOP-E regimen for patients with… (More)
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2004
2004
A 6-year-old male child was consulted in our ambulatory in Goundi missionary hospital in South Chad, in September 2001. He… (More)
Is this relevant?
1995
1995
PURPOSE To improve response and toxicity in treatment of non-Hodgkin's lymphomas (NHLs), a prospective single-arm trial was… (More)
Is this relevant?